In vitro susceptibility studies of vancomycin-resistant Enterococcus faecalis.

作者: D F Sahm , J Kissinger , M S Gilmore , P R Murray , R Mulder

DOI: 10.1128/AAC.33.9.1588

关键词: Broth microdilutionMicrobiologyBiologyVancomycinDaptomycinTeicoplaninDrug resistanceGlycopeptideEnterococcus faecalisAgar dilution

摘要: Vancomycin resistance exhibited by Enterococcus faecalis isolates V583, V586, and V587 is described. The vancomycin MICs ranged from 32 to 64 micrograms/ml. Although resistant vancomycin, the were susceptible teicoplanin (MIC, less than or equal 0.5 micrograms/ml). Such a glycopeptide susceptibility profile has not been previously described for E. faecalis. Time kill studies showed that adversely affected synergistic activity aminoglycoside combinations usually demonstrate against enterococci. However, ability detect varied with testing method used. Whereas broth microdilution, macrodilution, agar dilution methods detected resistance, disk-agar diffusion AutoMicrobic system Gram-Positive GPS-A card (Vitek Systems Inc., Hazelwood, Mo.) did not. To reliably establish incidence of such isolates, adjustments in some may be necessary.

参考文章(22)
A L Barry, C Thornsberry, R N Jones, Evaluation of teicoplanin and vancomycin disk susceptibility tests. Journal of Clinical Microbiology. ,vol. 23, pp. 100- 103 ,(1986) , 10.1128/JCM.23.1.100-103.1986
R R Facklam, M D Collins, Identification of Enterococcus species isolated from human infections by a conventional test scheme. Journal of Clinical Microbiology. ,vol. 27, pp. 731- 734 ,(1989) , 10.1128/JCM.27.4.731-734.1989
Grant O. Westenfelder, Vancomycin-Streptomycin Synergism in Enterococcal Endocarditis JAMA: The Journal of the American Medical Association. ,vol. 223, pp. 37- 40 ,(1973) , 10.1001/JAMA.1973.03220010023005
R J Fass, V L Helsel, In vitro activity of LY146032 against staphylococci, streptococci, and enterococci. Antimicrobial Agents and Chemotherapy. ,vol. 30, pp. 781- 784 ,(1986) , 10.1128/AAC.30.5.781
Roland Leclercq, Eliane Derlot, Jean Duval, Patrice Courvalin, Plasmid-mediated resistance to vancomycin and teicoplanin in Enterococcus faecium. The New England Journal of Medicine. ,vol. 319, pp. 157- 161 ,(1988) , 10.1056/NEJM198807213190307
G M Eliopoulos, C Thauvin, B Gerson, R C Moellering, In vitro activity and mechanism of action of A21978C1, a novel cyclic lipopeptide antibiotic. Antimicrobial Agents and Chemotherapy. ,vol. 27, pp. 357- 362 ,(1985) , 10.1128/AAC.27.3.357
MARCUS J. ZERVOS, Nosocomial Infection by Gentamicin-ResistantStreptococcus faecalis Annals of Internal Medicine. ,vol. 106, pp. 687- 691 ,(1987) , 10.7326/0003-4819-106-5-687
C. Watanakunakorn, C. Bakie, Synergism of Vancomycin-Gentamicin and Vancomycin-Streptomycin Against Enterococci Antimicrobial Agents and Chemotherapy. ,vol. 4, pp. 120- 124 ,(1973) , 10.1128/AAC.4.2.120
H Faruki, A C Niles, R L Heeren, P R Murray, Effect of calcium on in vitro activity of LY146032 against Clostridium difficile. Antimicrobial Agents and Chemotherapy. ,vol. 31, pp. 461- 462 ,(1987) , 10.1128/AAC.31.3.461